Olema Reaffirmed at Buy as Palazestrant Data and SERD Market Momentum Support Unchanged $36 Price Target
at www.tipranks.com (Mon, 21-Sep 6:36 AM)
Olema Pharmaceuticals (OLMA) Receives a Rating Update from a Top Analyst
at www.tipranks.com (Mon, 21-Sep 3:15 AM)
